Location History:
- Perkiomenville, PA (US) (1976 - 1977)
- Tuscon, AZ (US) (1978)
- Tucson, AZ (US) (1977 - 1980)
Company Filing History:
Years Active: 1976-1980
Title: Innovations by Albert J Begany: A Leader in Anti-Allergic Agents
Introduction: Albert J Begany is a notable inventor based in Tucson, AZ, with an impressive portfolio of 16 patents. His work primarily focuses on the development of oxamic acid derivatives, showcasing his commitment to addressing significant health issues, particularly within the realm of allergy treatment.
Latest Patents: Among his latest innovations are several anti-allergic agents derived from aromatic and heterocyclic oxamic acids. One patent describes compounds characterized by a unique formula where "A" is selected from a variety of groups, including alpha-naphthyl, beta-naphthyl, and various substituted phenyl moieties. Another patent emphasizes similar structures, incorporating a range of substituents tailored for effectiveness and safety. These discoveries represent vital advancements in pharmaceutical chemistry that hold promise for future therapies.
Career Highlights: Throughout his career, Albert J Begany has made significant contributions to the field of pharmaceutical inventions. His association with American Home Products Corporation has provided him a robust platform for research and development, allowing him to transform his innovative ideas into tangible products that benefit society.
Collaborations: In the pursuit of his inventive endeavors, Begany has worked alongside esteemed colleagues such as John H Sellstedt and Charles J Guinosso. Their collaboration has undoubtedly propelled advancements in their projects and has enriched the research atmosphere within their company.
Conclusion: Albert J Begany exemplifies the role of an inventive leader in the pharmaceutical sector. His dedication to developing anti-allergic agents has positioned him as a valuable contributor to advancements in medical science. With a strong patent portfolio and fruitful collaborations, his work continues to impact therapeutic solutions for allergy sufferers, underlining the importance of innovation in modern medicine.